BACKGROUND AND OBJECTIVES: Variants of cerebral amyloid angiopathy (CAA) have been increasingly reported. Iatrogenic CAA (iCAA) is a subtype arising in patients with a history of neurosurgery. Current etiopathogenetic hypotheses focus on previous exposure to contaminated materials, such as cadaveric dura, followed by a prion-like mechanism. CAA-related inflammation (CAA-ri) represents the inflammatory variant of CAA, usually with a good response to immunosuppressive therapy. To date, the association between iCAA and CAA-ri has not been clarified yet. This study reports cases of iCAA evolving into CAA-ri, emphasizing the clinical and radiologic overlaps between these conditions. METHODS: This retrospective observational study included patients with clinical and radiologic features of CAA-ri and a history of neurosurgical intervention, observed at 2 Italian neurologic centers. Patients were identified from CAA databases and screened for neurosurgical history before 1990. Eligible cases met diagnostic criteria for CAA-ri. Clinical data were anonymized and included surgical details, evidence of amyloid-β in the CNS (amyloid-PET, CSF biomarkers, genetic screening), and CAA-ri features (symptoms, imaging findings, treatment, and outcomes). RESULTS: We identified 6 patients with iCAA who developed clinical and instrumental features of CAA-ri during their follow-up. The mean age at neurosurgery was 17.2 years (range: <1-43) while the onset of CAA-ri occurred at 61.8 years (range: 48-79), with an average latency of 44.7 years (range: 36-59). Despite immunosuppressive treatment, 2 patients experienced a rapid decline in their clinical condition and deceased within a few months from CAA-ri onset. DISCUSSION: This study increases awareness about the potential occurrence of CAA-ri in patients with iCAA, confirming its aggressive nature and highlighting the importance of neuroinflammation in the pathogenesis of the disease. In these patients, CAA-ri seems to be associated with a severe clinical course and a poor response to steroid treatment, often resulting in a fatal outcome in the short term.

Storti, B., Negro, G., Orsani, G., Damavandi, P., Donelli, M., Cavarsaschi, E., et al. (2025). Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series. NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION, 12(6), 1-11 [10.1212/NXI.0000000000200470].

Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series

Storti B.;Negro G.;Orsani G.;Donelli M.;Cavarsaschi E.;Conti E.;Sala G.;Zoia C. P.;Ferrarese C.;
2025

Abstract

BACKGROUND AND OBJECTIVES: Variants of cerebral amyloid angiopathy (CAA) have been increasingly reported. Iatrogenic CAA (iCAA) is a subtype arising in patients with a history of neurosurgery. Current etiopathogenetic hypotheses focus on previous exposure to contaminated materials, such as cadaveric dura, followed by a prion-like mechanism. CAA-related inflammation (CAA-ri) represents the inflammatory variant of CAA, usually with a good response to immunosuppressive therapy. To date, the association between iCAA and CAA-ri has not been clarified yet. This study reports cases of iCAA evolving into CAA-ri, emphasizing the clinical and radiologic overlaps between these conditions. METHODS: This retrospective observational study included patients with clinical and radiologic features of CAA-ri and a history of neurosurgical intervention, observed at 2 Italian neurologic centers. Patients were identified from CAA databases and screened for neurosurgical history before 1990. Eligible cases met diagnostic criteria for CAA-ri. Clinical data were anonymized and included surgical details, evidence of amyloid-β in the CNS (amyloid-PET, CSF biomarkers, genetic screening), and CAA-ri features (symptoms, imaging findings, treatment, and outcomes). RESULTS: We identified 6 patients with iCAA who developed clinical and instrumental features of CAA-ri during their follow-up. The mean age at neurosurgery was 17.2 years (range: <1-43) while the onset of CAA-ri occurred at 61.8 years (range: 48-79), with an average latency of 44.7 years (range: 36-59). Despite immunosuppressive treatment, 2 patients experienced a rapid decline in their clinical condition and deceased within a few months from CAA-ri onset. DISCUSSION: This study increases awareness about the potential occurrence of CAA-ri in patients with iCAA, confirming its aggressive nature and highlighting the importance of neuroinflammation in the pathogenesis of the disease. In these patients, CAA-ri seems to be associated with a severe clinical course and a poor response to steroid treatment, often resulting in a fatal outcome in the short term.
Articolo in rivista - Articolo scientifico
Cerebral amyloid angiopathy, Iatrogenic cerebral amyloid angiopathy, CAA-related inflammation, Amyloid beta, Neuroinflammation, Prion-like transmission, Immunotherapy
English
9-ott-2025
2025
12
6
1
11
e200470
open
Storti, B., Negro, G., Orsani, G., Damavandi, P., Donelli, M., Cavarsaschi, E., et al. (2025). Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series. NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION, 12(6), 1-11 [10.1212/NXI.0000000000200470].
File in questo prodotto:
File Dimensione Formato  
Storti et al-2025-Neurology(R) neuroimmunology & neuroinflammation-VoR.pdf

accesso aperto

Descrizione: This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 1.48 MB
Formato Adobe PDF
1.48 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/574281
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
Social impact